Sanofi/GSK Vaccine Delay

Dec 11, 2020

A candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline exhibited an insufficient immune response in early-stage clinical trials, delaying the companies' vaccine development timeline, Reuters reports.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Cell Studies on SARS-CoV-2 B.1.1.7 Introductions, Microbiome HGT, Heterogeneity Within Tumors

In Cell this week: analysis of SARS-CoV-2 B.1.1.7 introductions to the US, increased horizontal gene transfer higher in gut microbiomes linked to industrialization, and more.

Genomic NFT

Nebula Genomics will be auctioning George Church's genome as a nonfungible token, according to The Scientist.

ACMG's Gregg Resigns

Anthony Gregg, the outgoing president of the American College of Medical Genetics and Genomics, has resigned after using racially insensitive language.

Interaction Prediction

Facebook has developed an artificial intelligence approach to predict how drugs interact in cells, New Scientist reports.

Menu